Outcomes after radiotherapy for squamous cell carcinoma of the eyelid

Janjira Petsuksiri, Steven J. Frank, Adam S. Garden, K. Kian Ang, William H. Morrison, K. S Clifford Chao, David I. Rosenthal, David L. Schwartz, Anesa Ahamad, Bita Esmaeli

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

BACKGROUND. Squamous cell carcinoma (SCC) of the eyelid is a rare malignancy with metastatic potential. In the current study, the outcomes of patients with SCC of the eyelid were evaluated after definitive and postoperative radiation therapy. METHODS. The medical records of all patients treated with radiotherapy for SCC of the eyelid at 1 institution between 1950 and 2005 were reviewed. Patient records were analyzed for clinical characteristics, pathologic features, radiation techniques, and outcomes. Survival rates were calculated using the Kaplan-Meier method; factors affecting survival were assessed using the log-rank test. RESULTS. During the study period, 39 patients with 42 eyelid SCCs were treated with radiotherapy. Thirty-two tumors were treated with primary radiotherapy and 10 were treated with postoperative radiotherapy after wide local excision. Surviving patients were followed for a median of 76 months. The 5-year disease-specific and overall survival rates for all patients were 86% and 71%, respectively. At 5 years, local, regional, and distant disease control rates for all tumors were 88%, 95%, and 97%, respectively. There were no significant differences in the 5-year local, regional, and distant control rates between tumors treated with definitive and those treated with postoperative radiotherapy. There were no grade 3 or 4 complications. CONCLUSIONS. Primary radiotherapy for SCC of the eyelid provides excellent locoregional control with reasonable complication rates and should be considered an alternative to surgery in selected patients.

Original languageEnglish (US)
Pages (from-to)111-118
Number of pages8
JournalCancer
Volume112
Issue number1
DOIs
StatePublished - Jan 1 2008

Fingerprint

Eyelids
Squamous Cell Carcinoma
Radiotherapy
Neoplasms
Survival Rate
Medical Records
Radiation
Survival

Keywords

  • Eyelid cancer
  • Postoperative radiotherapy
  • Radiation therapy
  • Skin cancer
  • Squamous cell carcinoma

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Petsuksiri, J., Frank, S. J., Garden, A. S., Ang, K. K., Morrison, W. H., Chao, K. S. C., ... Esmaeli, B. (2008). Outcomes after radiotherapy for squamous cell carcinoma of the eyelid. Cancer, 112(1), 111-118. https://doi.org/10.1002/cncr.23143

Outcomes after radiotherapy for squamous cell carcinoma of the eyelid. / Petsuksiri, Janjira; Frank, Steven J.; Garden, Adam S.; Ang, K. Kian; Morrison, William H.; Chao, K. S Clifford; Rosenthal, David I.; Schwartz, David L.; Ahamad, Anesa; Esmaeli, Bita.

In: Cancer, Vol. 112, No. 1, 01.01.2008, p. 111-118.

Research output: Contribution to journalArticle

Petsuksiri, J, Frank, SJ, Garden, AS, Ang, KK, Morrison, WH, Chao, KSC, Rosenthal, DI, Schwartz, DL, Ahamad, A & Esmaeli, B 2008, 'Outcomes after radiotherapy for squamous cell carcinoma of the eyelid', Cancer, vol. 112, no. 1, pp. 111-118. https://doi.org/10.1002/cncr.23143
Petsuksiri J, Frank SJ, Garden AS, Ang KK, Morrison WH, Chao KSC et al. Outcomes after radiotherapy for squamous cell carcinoma of the eyelid. Cancer. 2008 Jan 1;112(1):111-118. https://doi.org/10.1002/cncr.23143
Petsuksiri, Janjira ; Frank, Steven J. ; Garden, Adam S. ; Ang, K. Kian ; Morrison, William H. ; Chao, K. S Clifford ; Rosenthal, David I. ; Schwartz, David L. ; Ahamad, Anesa ; Esmaeli, Bita. / Outcomes after radiotherapy for squamous cell carcinoma of the eyelid. In: Cancer. 2008 ; Vol. 112, No. 1. pp. 111-118.
@article{5aa213eafdba4b5188900189006911a9,
title = "Outcomes after radiotherapy for squamous cell carcinoma of the eyelid",
abstract = "BACKGROUND. Squamous cell carcinoma (SCC) of the eyelid is a rare malignancy with metastatic potential. In the current study, the outcomes of patients with SCC of the eyelid were evaluated after definitive and postoperative radiation therapy. METHODS. The medical records of all patients treated with radiotherapy for SCC of the eyelid at 1 institution between 1950 and 2005 were reviewed. Patient records were analyzed for clinical characteristics, pathologic features, radiation techniques, and outcomes. Survival rates were calculated using the Kaplan-Meier method; factors affecting survival were assessed using the log-rank test. RESULTS. During the study period, 39 patients with 42 eyelid SCCs were treated with radiotherapy. Thirty-two tumors were treated with primary radiotherapy and 10 were treated with postoperative radiotherapy after wide local excision. Surviving patients were followed for a median of 76 months. The 5-year disease-specific and overall survival rates for all patients were 86{\%} and 71{\%}, respectively. At 5 years, local, regional, and distant disease control rates for all tumors were 88{\%}, 95{\%}, and 97{\%}, respectively. There were no significant differences in the 5-year local, regional, and distant control rates between tumors treated with definitive and those treated with postoperative radiotherapy. There were no grade 3 or 4 complications. CONCLUSIONS. Primary radiotherapy for SCC of the eyelid provides excellent locoregional control with reasonable complication rates and should be considered an alternative to surgery in selected patients.",
keywords = "Eyelid cancer, Postoperative radiotherapy, Radiation therapy, Skin cancer, Squamous cell carcinoma",
author = "Janjira Petsuksiri and Frank, {Steven J.} and Garden, {Adam S.} and Ang, {K. Kian} and Morrison, {William H.} and Chao, {K. S Clifford} and Rosenthal, {David I.} and Schwartz, {David L.} and Anesa Ahamad and Bita Esmaeli",
year = "2008",
month = "1",
day = "1",
doi = "10.1002/cncr.23143",
language = "English (US)",
volume = "112",
pages = "111--118",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Outcomes after radiotherapy for squamous cell carcinoma of the eyelid

AU - Petsuksiri, Janjira

AU - Frank, Steven J.

AU - Garden, Adam S.

AU - Ang, K. Kian

AU - Morrison, William H.

AU - Chao, K. S Clifford

AU - Rosenthal, David I.

AU - Schwartz, David L.

AU - Ahamad, Anesa

AU - Esmaeli, Bita

PY - 2008/1/1

Y1 - 2008/1/1

N2 - BACKGROUND. Squamous cell carcinoma (SCC) of the eyelid is a rare malignancy with metastatic potential. In the current study, the outcomes of patients with SCC of the eyelid were evaluated after definitive and postoperative radiation therapy. METHODS. The medical records of all patients treated with radiotherapy for SCC of the eyelid at 1 institution between 1950 and 2005 were reviewed. Patient records were analyzed for clinical characteristics, pathologic features, radiation techniques, and outcomes. Survival rates were calculated using the Kaplan-Meier method; factors affecting survival were assessed using the log-rank test. RESULTS. During the study period, 39 patients with 42 eyelid SCCs were treated with radiotherapy. Thirty-two tumors were treated with primary radiotherapy and 10 were treated with postoperative radiotherapy after wide local excision. Surviving patients were followed for a median of 76 months. The 5-year disease-specific and overall survival rates for all patients were 86% and 71%, respectively. At 5 years, local, regional, and distant disease control rates for all tumors were 88%, 95%, and 97%, respectively. There were no significant differences in the 5-year local, regional, and distant control rates between tumors treated with definitive and those treated with postoperative radiotherapy. There were no grade 3 or 4 complications. CONCLUSIONS. Primary radiotherapy for SCC of the eyelid provides excellent locoregional control with reasonable complication rates and should be considered an alternative to surgery in selected patients.

AB - BACKGROUND. Squamous cell carcinoma (SCC) of the eyelid is a rare malignancy with metastatic potential. In the current study, the outcomes of patients with SCC of the eyelid were evaluated after definitive and postoperative radiation therapy. METHODS. The medical records of all patients treated with radiotherapy for SCC of the eyelid at 1 institution between 1950 and 2005 were reviewed. Patient records were analyzed for clinical characteristics, pathologic features, radiation techniques, and outcomes. Survival rates were calculated using the Kaplan-Meier method; factors affecting survival were assessed using the log-rank test. RESULTS. During the study period, 39 patients with 42 eyelid SCCs were treated with radiotherapy. Thirty-two tumors were treated with primary radiotherapy and 10 were treated with postoperative radiotherapy after wide local excision. Surviving patients were followed for a median of 76 months. The 5-year disease-specific and overall survival rates for all patients were 86% and 71%, respectively. At 5 years, local, regional, and distant disease control rates for all tumors were 88%, 95%, and 97%, respectively. There were no significant differences in the 5-year local, regional, and distant control rates between tumors treated with definitive and those treated with postoperative radiotherapy. There were no grade 3 or 4 complications. CONCLUSIONS. Primary radiotherapy for SCC of the eyelid provides excellent locoregional control with reasonable complication rates and should be considered an alternative to surgery in selected patients.

KW - Eyelid cancer

KW - Postoperative radiotherapy

KW - Radiation therapy

KW - Skin cancer

KW - Squamous cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=37449024450&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37449024450&partnerID=8YFLogxK

U2 - 10.1002/cncr.23143

DO - 10.1002/cncr.23143

M3 - Article

C2 - 17963262

AN - SCOPUS:37449024450

VL - 112

SP - 111

EP - 118

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 1

ER -